Skip to main content
SpringerLink
Log in

Options for managing influenza are increasing

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. CDC Prevention and Control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000 Apr 14; 49 (RR-3): 1–38 Also available on line: URL: http://www.cdc.gov/epo/mmwr/preview/mmwrhtml/rr4903al.htm [Accessed 2001 Mar 14]

    Google Scholar 

  2. Monto AS, Fendrick AM. Developments in influenza prevention and treatment. A managed care perspective. Dis Manage Health Outcomes 2000 May; 7 (5): 235–43

    Article  Google Scholar 

  3. Cram P, Blitz SG, Monto A, et al. Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies. Pharmacoeconomics 2001; 19 (3): 223–30

    Article  PubMed  CAS  Google Scholar 

  4. Neuzil K, Reed G, Mitchel E, et al. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281 (10): 910–7

    Article  Google Scholar 

  5. American Lung Association. Influenza fact sheet [online]. Available from: URL: http://www.lungusa.org/diseases/influenza_factsheet.html [Accessed 2000 Nov 21]

  6. British National Formulary. No. 40. London: The Pharmaceutical Press, 2000 Sep: 298

  7. Holm KJ, Goa KL. Liposomal influenza vaccine. Biodrugs 1999 Feb; 11 (2): 137–44

    Article  PubMed  CAS  Google Scholar 

  8. Dooley M, Goa KL. Adjuvanted influenza vaccine. Biodrugs 2000 Jul; 14 (1): 61–9

    Article  PubMed  CAS  Google Scholar 

  9. Belshe R, Mendelman P, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338 (20): 1405–12

    Article  PubMed  CAS  Google Scholar 

  10. Nichol K, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated, intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282 (2): 137–44

    Article  PubMed  CAS  Google Scholar 

  11. Jackson HC, Roberts N, Wang M et al. Management of influenza. Use of new antivirals and resistance in perspective. Clin Drug Invest 2000 Dec; 20 (6): 447–54

    Article  CAS  Google Scholar 

  12. Zanamivir and oseltamivir: new treatment options in the management of influenza. D&TP 2000 Mar 27; 15 (6): 1-5

  13. Dunn CJ, Goa KL. Zanamivir: a review of its use in influenza. Drugs 1999 Oct; 58 (4): 761–84

    Article  PubMed  CAS  Google Scholar 

  14. McClellan K, Perry CM. Oseltamivir: a review of its use in influenza. Drugs 2001; 61 (2): 263–83

    Article  PubMed  CAS  Google Scholar 

  15. Snacken R, Influenza Diagnosis Working Party. Managing influenza in primary care: a practical guide to clinical diagnosis. Dis Manage Health Outcomes 2000 Aug; 8: 79–85

    Article  Google Scholar 

  16. Blitz S, Cram P, Chernew M, et al. Cost-effective use of innovative influenza therapy: what a difference a day makes? [abstract]. Presented at the 23rd Annual Meeting of the Society of General Internal Medicine (SGIM); 2000 May 4–6; Boston (MA)

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Options for managing influenza are increasing. Drugs Ther. Perspect 17, 12–15 (2001). https://doi.org/10.2165/00042310-200117110-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117110-00003

Keywords

Search

Navigation